Motooka Satoru | Drug Safety Research Laboratories Eisai Co. Ltd.

スポンサーリンク

概要

• Motooka Satoruの詳細を見る
• 同名の論文著者
• Drug Safety Research Laboratories Eisai Co. Ltd.の論文著者

関連著者

• MOTOOKA Satoru

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• Motooka Satoru

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Sagami Fumio

  第一三共安全性研究所

• Sagami Fumio

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Sagami Fumio

  Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers

• Sagami Fumio

  Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.

• AOKI Toyohiko

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• SATO Gen

  Drug Safety Research Laboratories

• Sato Gen

  Drug Safety And Disposition

• Sato Gen

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Katoh Satoru

  Drug Safety Research Laboratories Eisai Co. Ltd.

• HOSOKAWA Satoru

  Drug Safety Research Lab., Eisai Co., Ltd.

• Inagami Atsushi

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Sekido Tohru

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• KATSUYAMA Hiromi

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• KATO Satoru

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• Sekido Tohru

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Katsuyama Hiromi

  Drug Safety Research Laboratories Eisai Co. Ltd.

• SUMIGAMA Shuji

  Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.

• Sumigama Shuji

  Drug Safety & Disposition Research Laboratories Eisai Co. Lid.

• Hosokawa Satoru

  Drug Safety And Disposition

• Hosokawa Satoru

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Aoki Toyohiko

  Drug Safety Japan Global Drug Safety Biopharmaceutical Assessments Core Function Unit

• Sagami Fumio

  Drug Safety Research Laboratories Eisai Co. Ltb.

• Kato Satoru

  Drug Safety Research Laboratories Eisai Co. Ltd.

もっと見る 閉じる

著作論文

• P6-44 The effects of chronic dietary restriction on biological characteristics in Crj:CD(SD)IGS rats(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
• "B-5 Modification of Drug Conjugation Pathway by Repeated Administration of Conjugating Enzyme Inhibitors in Rats.

スポンサーリンク